Followers | 4 |
Posts | 293 |
Boards Moderated | 0 |
Alias Born | 02/02/2015 |
Wednesday, November 15, 2017 4:50:53 PM
VANCOUVER, BC–(Marketwired – Nov 14, 2017) – Breathtec Biomedical, Inc. (CSE: BTH) (OTCQB: BTHCF) (the “Company” or “Breathtec“) – at the request of the Investment Industry Regulatory Organization of Canada, Breathtec has confirmed that its management is unaware of any material change in the operations of the Company that would account for the recent market activity. The Company will continue to provide updates of any material changes if and when they occur.
.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM